157 related articles for article (PubMed ID: 17536509)
1. [Hepatitis C virus--structure, replication and therapeutical opportunities and the phenomenon of resistance].
Kowala-Piaskowska A
Postepy Biochem; 2006; 52(4):399-407. PubMed ID: 17536509
[TBL] [Abstract][Full Text] [Related]
2. Resistance to direct antiviral agents in patients with hepatitis C virus infection.
Sarrazin C; Zeuzem S
Gastroenterology; 2010 Feb; 138(2):447-62. PubMed ID: 20006612
[TBL] [Abstract][Full Text] [Related]
3. Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients.
Bolcic F; Bull L; Martinez L; Reynoso R; Salomon H; Arduino R; Barnett B; Quarleri J
Intervirology; 2008; 51(4):261-4. PubMed ID: 18824873
[No Abstract] [Full Text] [Related]
4. In vitro replication models for the hepatitis C virus.
Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular biology of HCV infection and hepatitis.
Tang H; Grisé H
Clin Sci (Lond); 2009 Jun; 117(2):49-65. PubMed ID: 19515018
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of hepatitis C virus genotypes and quasispecies.
Farci P; Purcell RH
Semin Liver Dis; 2000; 20(1):103-26. PubMed ID: 10895435
[TBL] [Abstract][Full Text] [Related]
7. Intra-host genetic heterogeneity of hepatitis C virus and biomedical implications.
Clementi M
J Biol Regul Homeost Agents; 2003; 17(2):120-4. PubMed ID: 14518708
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon.
Aus dem Siepen M; Oniangue-Ndza C; Wiese M; Ross S; Roggendorf M; Viazov S
Virus Res; 2007 Apr; 125(1):109-13. PubMed ID: 17254660
[TBL] [Abstract][Full Text] [Related]
9. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
Xu J; Liu S; Xu Y; Tien P; Gao G
Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
[TBL] [Abstract][Full Text] [Related]
10. Differences in viral kinetics between genotypes 1 and 2 of hepatitis C virus after single administration of standard interferon-alpha.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Atsumi H; Takagi M; Nakano S; Arakawa T; Fujimori M
J Med Virol; 2009 Aug; 81(8):1354-62. PubMed ID: 19551828
[TBL] [Abstract][Full Text] [Related]
11. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N
Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345
[TBL] [Abstract][Full Text] [Related]
12. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C: changing genotype distribution with important implications for patient management.
van Soest H; Boland GJ; van Erpecum KJ
Neth J Med; 2006 Apr; 64(4):96-9. PubMed ID: 16609154
[TBL] [Abstract][Full Text] [Related]
14. Genetic variability and diversity of intracellular genome-length hepatitis C virus RNA in long-term cell culture.
Kato N; Abe K; Mori K; Ariumi Y; Dansako H; Ikeda M
Arch Virol; 2009; 154(1):77-85. PubMed ID: 19082684
[TBL] [Abstract][Full Text] [Related]
15. Host factors involved in the replication of hepatitis C virus.
Moriishi K; Matsuura Y
Rev Med Virol; 2007; 17(5):343-54. PubMed ID: 17563922
[TBL] [Abstract][Full Text] [Related]
16. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
[TBL] [Abstract][Full Text] [Related]
17. A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy.
Ogata K; Kashiwagi T; Iwahashi J; Hara K; Honda H; Ide T; Kumashiro R; Kohara M; Sata M; Watanabe H; Hamada N
Arch Virol; 2008; 153(8):1575-9. PubMed ID: 18592133
[TBL] [Abstract][Full Text] [Related]
18. A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication.
Dansako H; Ikeda M; Abe K; Mori K; Takemoto K; Ariumi Y; Kato N
Virus Res; 2008 Oct; 137(1):72-9. PubMed ID: 18602954
[TBL] [Abstract][Full Text] [Related]
19. [Physiopathology of HCV infection].
Zarski JP; Souvignet C
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B154-62. PubMed ID: 12180283
[No Abstract] [Full Text] [Related]
20. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
